| 注册
首页|期刊导航|中国药理学通报|STING抑制剂在脑卒中后炎症反应中的调控作用与研究进展

STING抑制剂在脑卒中后炎症反应中的调控作用与研究进展

张雪婷 黄文鹏 胡凯超 楚世峰 陈乃宏

中国药理学通报2026,Vol.42Issue(4):629-634,6.
中国药理学通报2026,Vol.42Issue(4):629-634,6.DOI:10.12360/CPB202508102

STING抑制剂在脑卒中后炎症反应中的调控作用与研究进展

The regulatory role and research advances of STING inhibitors in post-stroke inflammation

张雪婷 1黄文鹏 1胡凯超 1楚世峰 2陈乃宏3

作者信息

  • 1. 长春中医药大学药学院,吉林 长春 130117
  • 2. 中国医学科学院药物研究所,北京 100050
  • 3. 长春中医药大学药学院,吉林 长春 130117||中国医学科学院药物研究所,北京 100050
  • 折叠

摘要

Abstract

Stroke is an acute neurological injury caused by a sudden interruption of cerebral blood supply,which imposes a heavy burden on patients due to its high mortality and disability rates.Following a stroke,the cGAS-STING pathway becomes activated,strongly inducing a type Ⅰ interferon response that ex-acerbates stroke-related damage.Targeted inhibition or degra-dation of STING can alleviate excessive inflammatory signaling and improve therapeutic outcomes.Strategies for STING inhibi-tion include the use of covalent inhibitors and competitive an-tagonists that target the ligand-binding domain(LBD)to block cyclic dinucleotide(CDN)binding,thereby suppressing STING activation.In addition,selective degradation of STING via the ubiquitin-proteasome system has also demonstrated promising efficacy.This review examines the role of the cGAS-STING pathway in stroke and summarizes recent advances in the development of STING inhibitors and degraders for the treat-ment of stroke.We aim to provide new perspectives and strate-gies to support the development of innovative anti-stroke thera-pies targeting STING.

关键词

脑卒中/cGAS-STING通路/STING抑制剂/STING降解剂/神经炎症/药物治疗

Key words

stroke/cGAS-STING pathway/STING inhibitors/STING degraders/neuroinflammation/pharmacological therapy

分类

医药卫生

引用本文复制引用

张雪婷,黄文鹏,胡凯超,楚世峰,陈乃宏..STING抑制剂在脑卒中后炎症反应中的调控作用与研究进展[J].中国药理学通报,2026,42(4):629-634,6.

基金项目

国家自然科学基金资助项目(No U2202214) (No U2202214)

中国药理学通报

1001-1978

访问量1
|
下载量0
段落导航相关论文